Analystreport

Ionis Pharmaceuticals Inc (NASDAQ: IONS) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $74.00 price target on the stock.

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com